Your browser doesn't support javascript.
loading
Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.
Bindal, Poorva; Najjar, Mimi; Koehn, Kelly; Godara, Amandeep; Sborov, Douglas W; McClune, Brian; Julian, Kelley; Wagner, Charlotte; Mohyuddin, Ghulam Rehman.
Afiliación
  • Bindal P; Division of Hematology and Hematological Malignancies, University of Massachusetts, Worcester, MA, USA.
  • Najjar M; Department of Medicine, University of Balamand, Beirut, Lebanon.
  • Koehn K; Mercy Health Center, Springfield, MO, USA.
  • Godara A; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Sborov DW; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • McClune B; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Julian K; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Wagner C; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Mohyuddin GR; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Leuk Lymphoma ; 64(7): 1340-1343, 2023.
Article en En | MEDLINE | ID: mdl-37170589
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos